Colorcon Opens Major Facility in India - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Colorcon Opens Major Facility in India

PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 5

Colorcon announced that it has completed a major expansion of its South Asia production facility in Verna, Goa, India. The Goa site operates under schedule M of the Indian FDA and IPEC guidelines, with Colorcon accredited to the latest ISO 9001 standard.

Colorcon provides film coatings, modified-release technologies, functional excipients and tablet-design services to the pharmaceutical industry. The Goa plant is one of six Colorcon manufacturing plants dedicated to film coatings. These plants are strategically located close to key customer centers in India, China, Europe, North America and Japan.

Subodh Priolkar, regional managing director for South Asia, said during the opening event that the investment would enable Colorcon to continue to meet the needs of its customers through security of supply and short lead times.

Martti Hedman, CEO of Colorcon, added that India is one of the fastest growing pharmaceutical markets and is also the most important production cluster of generic medicines for global markets. “Colorcon is investing heavily in India to support its customers during both development and manufacture,” Hedman said. “Speed to market, cost to produce and consistently high product quality are our customers’ strategic objectives.”

Source: Colorcon

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
11%
Protecting the supply chain
37%
Expedited reviews of drug submissions
11%
More stakeholder involvement
11%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here